Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells
<p>Abstract</p> <p>Background</p> <p>In breast cancer, the HER2/<it>neu </it>oncoprotein, which belongs to the epidermal growth factor receptor family, may trigger activation of the phosphoinositide-3 kinase (PI3K)/Akt pathway, which controls cell proliferat...
Main Authors: | Kim Chul-Woo, Jeon Yoon-Kyung, Jang Ji-Young |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/391 |
Similar Items
-
Suppression of HER2/Neu-Overexpressing Cancers by siRNA against HER2/Neu Proto-Oncogene
by: Zong-Keng Kuo, et al.
Published: (2006) -
Suppression of cancer progression by MGAT1 shRNA knockdown.
by: Reza Beheshti Zavareh, et al.
Published: (2012-01-01) -
ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
by: Lu Zheng, et al.
Published: (2012-01-01) -
Silencing Human Rb2/p130 with shRNA
by: Eleonora Leucci, et al.
Published: (2007-01-01) -
Magnolol suppresses HER2/neu expression and its mediated Metastasis
by: Yi-Ting Cheng, et al.
Published: (2008)